PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacist Penicillin Allergy Interview Delabels Without Skin Testing

penicillin allergybeta-lactamdelabelingantimicrobial stewardshippharmacist-led interventionABLE processretrospective cohortVeterans Affairsmedication safety Medication Safety

Background Information

Pharmacist-led interviews enhance penicillin allergy documentation accuracy.

Penicillin allergies are often inaccurately documented, leading to inappropriate antibiotic use. This study explores a pharmacist-led method to improve allergy documentation. In the study, 17.1% (6 of 35) of participants had their allergy profile modified compared to none in the control group, showing statistically significant improvement (P < .03). The Allergy to β-Lactam Evaluation (ABLE) process demonstrates potential for enhancing allergy documentation accuracy, despite its small sample size, which may limit generalizability. Pharmacist-led interviews using the ABLE process can improve penicillin allergy documentation.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Puckett JC, Powers C, Shin M, Larson R

Citation: Puckett JC, Powers C, Shin M, et al. Implementation of a Pharmacist-Led Penicillin Allergy Interview at a Veterans Care Facility. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2026;43(3):106-109. doi:10.12788/fp.0684

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →